ライフサイエンスコーパス: at risk for

1 Cirrhosis patients at risk for 3-month postdischarge mortality can be ident

2 ative pain trajectories identify populations at risk for 30-day readmissions and ED visits, and do no

3 Preterm infants are at risk for a broad spectrum of neurobehavioral disabili

4 Higher percentages of unit patients at risk for a hospital-acquired pressure ulcer and highe

5 The cohort was at risk for a median of six (range, one to nine) complic

6 s that the death of a parent places children at risk for a number of negative outcomes.

7 vascular coupling in NE may identify infants at risk for abnormal outcomes.

8 s indicator of network hyperexcitability are at risk for accelerated cognitive decline and might bene

9 Injury Prediction Score identifies patients at risk for acute respiratory distress syndrome in the e

10 th inhaled budesonide/formoterol in patients at risk for acute respiratory distress syndrome is feasi

11 ts admitted through the emergency department at risk for acute respiratory distress syndrome.

12 elevated polygenic risk for MDD may also be at risk for AD.

13 onal substance use or gambling; participants at risk for addictive behaviors; and studies using the s

14 ys to best identify subgroups of AD patients at risk for ADHD are poorly understood.

15 nd medical characteristics identify patients at risk for admission to the ICU and mortality and provi

16 ted and acquired CV disease, and may be most at risk for adverse CV outcomes during intense physical

17 Survivors of Wilms tumor (WT) are at risk for adverse health and social outcomes but risks

18 Neonates undergoing noncardiac surgery are at risk for adverse outcomes.

19 types, where individuals become concurrently at risk for all of their partners' HPV types when they e

20 he intraindividual correlation between times-at-risk for all HPV infections is not generally consider

21 g for RVs before HCT might identify patients at risk for allo-LSs.

22 sive tests to identify older healthy persons at risk for Alzheimer disease (AD) for enrollment in AD

23 Patients and individuals at risk for Alzheimer's disease show reduced glucose met

24 otal of 1453 of the 2900 individuals (50.1%) at risk for AMD were followed up after 6 years (mean [SD

25 e identified patient populations that remain at risk for an event at a median follow-up of 24 years f

26 mpared with typically developing boys, those at risk for antisocial behavior in general (irrespective

27 atening condition in that it places patients at risk for aortic dissection or rupture.

28 , 2012, and November 17, 2014, 7673 patients at risk for ARDS (Lung Injury Prediction Score >/=4) in

29 Current approaches to identify patients at risk for arrhythmia are, however, of low sensitivity

30 ion, those with established ASCVD, and those at risk for ASCVD.

31 magnetic resonance imaging study of infants at risk for ASD was carried out on 343 infants, who unde

32 ine to stop passive smoking (PS) in children at risk for asthma.

33 Like other studies, systematic reviews are at risk for bias from a number of sources.

34 Early identification of PCa patients at risk for biochemical recurrence (BCR) post-therapy wi

35 anage patients on NOACs who bleed or who are at risk for bleeding.

36 osure; health care and public safety workers at risk for blood exposure; adults with chronic liver di

37 ive to healthy individuals, those with BP or at risk for BP exhibited increased reaction time variabi

38 arriers to improve the detection of families at risk for breast or ovarian cancer.

39 Patients with cPRA of 80% or greater are at risk for CAMR even if no DSA is detected.

40 lace their respective human and murine hosts at risk for cancer.

41 , sometimes report pain when walking and are at risk for cardiac arrthymias.

42 Individuals with poor postnatal growth are at risk for cardiovascular and metabolic problems as adu

43 of vitamin D supplementation in individuals at risk for cardiovascular disease.

44 ed in patients with large hemispheric stroke at risk for cerebral oedema.

45 millions of chronically infected individuals at risk for cirrhosis and hepatocellular carcinoma.

46 tional tool for managing allo-HCT recipients at risk for CMV reactivation needs further validation in

47 opoietic stem-cell transplantation (HCT) are at risk for CMV reactivation.

48 telemonitoring of patients with AMD who are at risk for CNV was cost-effective compared with schedul

49 rticles were identified, and 12 (922 fetuses at risk for CoA) articles were included.

50 n toward identifying individuals potentially at risk for cognitive decline associated with preclinica

51 ts at the preclinical stage of AD who may be at risk for cognitive impairment and eligible for inclus

52 -viral antigen, MUC1, in healthy individuals at-risk for colon cancer.

53 tify individuals from the general population at risk for conversion to a clinical diagnosis of PD.

54 e changes have not been evaluated in smokers at risk for COPD.

55 e the optimal management of patients with or at risk for CRT.

56 We calculated those at risk for cryptococcal infection, specifically those w

57 point-based risk score can identify patients at risk for CVD complications after OLT surgery (availab

58 and myocardial ischemia, identifies patients at risk for CVD death, but is not routinely measured in

59 btle vascular impairments in this population at risk for CVD such as stroke or WMHs.

60 e number of outcome events and using cohorts at-risk for CVD (rather than with established CVD).

61 oietic cell transplant (allo-HCT) recipients at risk for cytomegalovirus (CMV) reactivation from thos

62 A significant number of patients are at risk for DDIs if treated with the recently approved D

63 t ventricular dysfunction post STEMI who are at risk for death and major morbidity.

64 Identification of patients with cirrhosis at risk for death within 3 months of discharge from the

65 ALL who were age < 10 years at diagnosis are at risk for deficits in IQ and PS in the absence of cran

66 regions in subarachnoid hemorrhage patients at risk for delayed cerebral ischemia across a wide rang

67 Fifty-two patients at risk for delayed cerebral ischemia after aneurysmal s

68 ent growth in the population of older people at risk for dementia.

69 gies are needed to identify patients who are at risk for dementia.

70 ts inclusion in the screening of individuals at risk for developing AD.

71 etion as a potential therapy for individuals at risk for developing AD.

72 ifying patients with type 2 diabetes who are at risk for developing AD.

73 Identifying individuals at risk for developing Alzheimer disease (AD) is of utmo

74 A total of 4819 participants were at risk for developing AMD based on fundus images obtain

75 on may prove useful for identifying children at risk for developing asthma with hayfever.

76 found in 20% of mothers whose children are at risk for developing autism has defined an additional

77 found in ~20% of mothers whose children are at risk for developing autism has defined an additional

78 pharmacological inhibitor to treat patients at risk for developing CKD and TIF.

79 ed, direct contact with measles patients are at risk for developing disease despite evidence of prior

80 they also may help identify patients who are at risk for developing early severe manifestations of Fa

81 3%) patients with nonmalignant liver disease at risk for developing HCC (P < 0.0001).

82 Although children with NF1 are at risk for developing low-grade gliomas of the optic pa

83 ntial biomarkers for identifying individuals at risk for developing MDD.

84 to determine whether some subtypes are more at risk for developing other allergic diseases.

85 an OGTT before surgery can identify patients at risk for developing PHH after RYGB.

86 ce: Nonwhite organ transplant recipients are at risk for developing skin cancer posttransplantation.

87 with adverse early life experiences who are at risk for developing substance use disorders.

88 in recently traumatized individuals who are at risk for developing trauma-related disorders.

89 set of surveillance guidelines for children at risk for development of retinoblastoma.

90 able information for identifying individuals at risk for diabetes and cardiometabolic disorders.

91 ally relevant among children who are already at risk for diabetic nephropathy.

92 tion is due to correlation between the times-at-risk for different HPV types, where individuals becom

93 identifying modern ecosystems that are most at risk for disappearing should current pressures on the

94 Identification of patients at risk for disease progression would be useful for clin

95 t of strategies that can identify recipients at risk for disease recurrence.

96 ure interventions should focus on those most at risk for early loss from care as programs continue to

97 is very difficult to treat, and patients are at risk for early morbidity and mortality from complicat

98 ografts in both high-acuity liver recipients at risk for early mortality and recipients who may regai

99 take stable antiretroviral therapy (ART) are at risk for early onset of age-related diseases.

100 se of rVSVDeltaG-ZEBOV-GP vaccine in persons at risk for Ebola virus disease.

101 onse or primary protection in selected areas at risk for emergence of poliovirus type 2 during the ne

102 ssment of endocrine function in CBTS who are at risk for endocrine damage.

103 fter aneurysm repair could place the patient at risk for endoleak or sac rupture.

104 s of ET patients as well as healthy subjects at risk for ET.

105 g or disseminated irregularly, people may be at risk for exposure to rumors that fill the information

106 hreatened animal groups, with 32% of species at risk for extinction.

107 but identifies most patients (65%) as being at risk for fall.

108 Medicare beneficiaries with cancer are at risk for financial hardship given increasingly expens

109 whereas coastal cities vulnerable to SLR are at risk for flooding from multiple drivers (e.g., extrem

110 survivorship and a population of individuals at risk for further cardiovascular events, including rec

111 Exudative fellow eyes remained at risk for further vision decline in later years under

112 e whether suPAR levels can identify children at risk for future CKD.

113 odialysis initiation would identify patients at risk for future CUA in a matched case-control study u

114 ventricular ejection fraction (LVEF) remain at risk for future deterioration of LVEF.

115 Targeting individuals at risk for glaucoma in underserved communities in Phila

116 A total of 1649 individuals at risk for glaucoma who were examined and treated in 43

117 event in disease progression, creating high-at-risk-for-harm communities.

118 e, there is a large reservoir of individuals at risk for HBV reactivation in the general population.

119 The population at risk for HBV reactivation includes those who either c

120 reated for hematological malignancies remain at risk for HBV reactivation.

121 liver masses were identified in 178 patients at risk for HCC but without established extrahepatic mal

122 For individuals at risk for HCC, surveillance usually involves ultrasono

123 To identify patients at risk for HCC, we evaluated serum levels of immune med

124 n-HCC malignancy in a population of patients at risk for HCC.

125 to identify subclinical changes in patients at risk for HCM and to evaluate the effects of intervent

126 Among the 983 research participants at risk for HD in the longitudinal cohort, 345 (35.1%) c

127 Participants included 983 unaffected adults at risk for HD who had chosen to remain unaware of their

128 toantibody profiles in hypertensive subjects at risk for heart failure.

129 presentation and can help stratify patients at risk for hematoma expansion.

130 In patients with major bleeding or at risk for hemorrhagic complications, administration of

131 lection for imaging examinations in patients at risk for hepatocellular carcinoma (HCC).

132 ajority of older adults in the community are at risk for HF (Stages A or B), appreciably more compare

133 LV ejection fraction in identifying persons at risk for HF hospitalization or death.

134 tepwise model) whether grouped with patients at risk for HFpEF or not.

135 Patients either at risk for HFpEF or with HFpEF demonstrated similarly h

136 Over a median of 1.9 years, 61 patients at risk for HFpEF or with HFpEF experienced adverse even

137 Among those at risk for HFpEF or with HFpEF, the actual diagnosis of

138 prevalent both in those with HFpEF and those at risk for HFpEF, similarly associating with disease se

139 MF was similarly prevalent in those with or at risk for HFpEF.

140 nge {IQR}] age, 56 [44-66] years), 250 were "at risk" for HFpEF given elevated brain-type natriuretic

141 is (PrEP) as a prevention option for persons at risk for HIV acquisition.

142 -containing PrEP over 48 weeks in U.S. women at risk for HIV infection.

143 enrolled a diverse sample of adolescent MSM at risk for HIV who consented to study participation.

144 ment following viral suppression in patients at risk for HIV-associated COPD.

145 Previous studies investigating patients at risk for hospital readmissions focus on medical servi

146 althcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventil

147 For young South African women at risk for human immunodeficiency virus (HIV) infection

148 lso estimated the sizes of 4 key populations at risk for human immunodeficiency virus infection in Rw

149 d be effectively applied to monitor patients at risk for hyper/hypokalemia.

150 llow for identification of HIV-1-controllers at risk for immunologic progression, and provide avenues

151 y lead to earlier identification of patients at risk for impaired neuropsychological outcome with the

152 Most toddlers were at risk for inadequate intakes of vitamins D and E and h

153 myocardial infarction (STEMI) victims remain at risk for infarct expansion, heart failure, reinfarcti

154 vaccinated adults (including pregnant women) at risk for infection due to sexual, percutaneous, or mu

155 d and body fluid exposures place individuals at risk for infection with bloodborne pathogens.

156 An estimated 390 million people are at risk for infection with DENV and there are no effecti

157 ed with hepatitis C virus, and many more are at risk for infection.

158 be the best strategy for identifying youths at risk for initiating alcohol use during adolescence.

159 ity to infect unvaccinated infants and those at risk for insufficient immunity (too young to be vacci

160 The appropriate management of pregnancies at risk for intrauterine growth restriction relies on ac

161 sis (SYNTAX score) in a cohort of 351 adults at risk for ischemic cardiovascular disease.

162 iSpec to measure total bilirubin in neonates at risk for jaundice at Queen Elizabeth Central Hospital

163 whether betamethasone administered to women at risk for late preterm delivery decreases the risks of

164 Administration of betamethasone to women at risk for late preterm delivery significantly reduced

165 prospective longitudinal studies of infants at risk for later diagnosis.

166 ole in preventing cardiac arrest in patients at risk for life-threatening ventricular arrhythmias.

167 In a prospective study of individuals at risk for liver fibrosis due to alcohol consumption, w

168 After surgery alone, patients may remain at risk for local recurrences and/or metastatic disease.

169 Patients with noninfectious uveitis are at risk for long-term complications of uncontrolled infl

170 dhood acute lymphoblastic leukemia (ALL) are at risk for low bone mineral density (BMD) and frail hea

171 l-age children born preterm are particularly at risk for low mathematical achievement, associated wit

172 correction of tetralogy of Fallot (TOF) are at risk for major complications.

173 th psoriasis, regardless of severity, may be at risk for major depression.

174 None of the tumors were considered at risk for malignant transformation at the time; for ex

175 igh proportion of Chinese Americans might be at risk for MD and associated visual complications.

176 facilitate the identification of individuals at risk for melanoma.

177 suggested but can be considered for patients at risk for metastases or who exhibit symptoms or other

178 r pathways have helped to recognize patients at risk for metastasis.

179 diagnosed with high-risk prostate cancer are at risk for metastatic progression after primary treatme

180 igns has been developed to identify patients at risk for mortality.

181 This study included 100 participants at risk for MS, with 41 at higher risk (40 women [98%])

182 abnormalities among asymptomatic individuals at risk for MS.

183 , little is known about what places patients at risk for multiple complications or which complication

184 a tool for identifying HIV-infected persons at risk for NCI.

185 entify the intestinal microbiota of patients at risk for NEC.

186 identity, represent a vulnerable population at risk for negative mental health and substance use out

187 hood acute lymphoblastic leukaemia (ALL) are at risk for neurocognitive deficits that affect developm

188 dhood acute lymphoblastic leukemia (ALL) are at risk for neurocognitive deficits that are associated

189 ) treated with CNS-directed chemotherapy are at risk for neurocognitive deficits.

190 Long-term survivors of osteosarcoma are at risk for neurocognitive impairment, which is related

191 heterosexual transmission, MSM and PWID are at risk for non-B infections.

192 ay an important role in determining patients at risk for nonadherence to a subsequent medication for

193 s important for clinicians to identify women at risk for noninitiation.

194 at the start of training that put residents at risk for not completing training.

195 e findings suggest that children genetically at risk for obesity are predisposed to represent reward

196 ren (ages 9-12 y), we observed that children at risk for obesity exhibited stronger responses to food

197 mprehensive plan will benefit people who are at risk for or affected by CKD worldwide.

198 tegic planning to improve the lives of women at risk for or living with cardiovascular disease.

199 theless, for those patients with HCM who are at risk for (or experience) disease-related complication

200 esonance (MR) images in older adults with or at risk for osteoarthritis of the knee.

201 pective cohort study of older adults with or at risk for osteoarthritis of the knee.

202 SHFP edema on MR images in subjects with or at risk for osteoarthritis of the knee.

203 precancerous or early cancers in individuals at risk for pancreatic cancer.

204 Detecting individuals at risk for Parkinson disease (PD) during the prodromal

205 mework of genetic evaluation and testing men at risk for PCA-a clinically heterogeneous disease.

206 to undergo coronary artery surgery and were at risk for perioperative complications to receive aspir

207 to undergo coronary-artery surgery and were at risk for perioperative complications to receive aspir

208 g firearm possession by persons deemed to be at risk for perpetrating intimate partner abuse may save

209 this threshold are common among populations at risk for PH, the relevance of mPAP <25 mm Hg to clini

210 vels of preoperative depressive symptoms are at risk for poor clinical outcomes after HIPEC + CS, inc

211 e altered developmental trajectories and are at risk for poor developmental outcomes.

212 of HRQoL can help identify patients who are at risk for poor HRQoL in the recovery or rehabilitation

213 and more accurate identification of patients at risk for poor outcomes or drug-related adverse effect

214 built, including: (1) screening for patients at risk for poor outcomes, (2) integrating patient- and

215 r as a consequence of viral reactivation are at risk for postherpetic neuralgia (PHN), a painful and

216 T), may be similarly beneficial for patients at risk for postoperative vertical deviation or incyclot

217 s correlated with tumor biology and patients at risk for posttransplantation recurrence, and it may b

218 ted lymph node examination are thought to be at risk for potentially harboring occult disease.

219 ols enabling clinicians to identify patients at risk for PPCS do not exist.

220 IONALE: Individuals with cystic fibrosis are at risk for prolonged drops in lung function, clinically

221 ition into adulthood all family members were at risk for psychosocial difficulties as they mutually i

222 prove useful as a tool for identifying those at risk for psychotic illness.

223 a viable therapeutic target in women who are at risk for PTB and associated complications in the affe

224 be considered to identify and treat patients at risk for pulmonary embolism.

225 chocardiography, helps identify SCD patients at risk for pulmonary hypertension, but definitive diagn

226 inority (SGM) populations as a diverse group at risk for receiving disparate care and having suboptim

227 group of patients with breast cancer who are at risk for receiving nonguideline breast cancer treatme

228 se patients with HPV-positive cancer who are at risk for recurrence and poor survival is critical in

229 e networks to reduce the percentage of nodes at risk for refusing treatment in MDA to below 25%.

230 (CLL), patients with high-risk genetics are at risk for relapse and have a poor prognosis.

231 may be added to glucocorticoids in patients at risk for relapse and in those with glucocorticoid-rel

232 t there continue to be subgroups of patients at risk for relapse for which prognostic criteria cannot

233 However, identification of patients at risk for relapse remains challenging.

234 Patients remain at risk for relapse, and additional approaches to deplet

235 oposed as a biomarker for patients having or at risk for renal disease, is described in this work.

236 ic screening is recommended for all children at risk for retinoblastoma above the population risk.

237 Screening recommendations for children at risk for retinoblastoma.

238 sizes the importance of studying individuals at risk for rheumatoid arthritis (pre-RA) and those with

239 To describe the characteristics of eyes at risk for ROP to provide insights into what types of R

240 Participants were premature infants at risk for ROP with a known ROP outcome.

241 Participants included 7483 premature infants at risk for ROP with a known ROP outcome.

242 and bedside clinical examination of infants at risk for ROP.

243 t of xerostomia, characteristics of patients at risk for salivary gland dysfunction, and whether radi

244 o individual patients generally and patients at risk for SCA and sudden cardiac death in particular i

245 diac disease, the identification of patients at risk for SCA could save many lives.

246 25 years, but identifying mutation carriers at risk for SCD is still a challenge and currently the o

247 ated with cranial radiation therapy (RT) are at risk for sensorineural hearing loss (SNHL).

248 lliliter of blood, who were considered to be at risk for serious adverse events, and exclude them fro

249 pid, point-of-care identification of persons at risk for serious adverse events.

250 mmon birthmarks, thereby identifying infants at risk for serious complications, and provide novel the

251 Children with Progeria are at risk for serious ophthalmic complications owing to oc

252 delivering timely care to premature infants at risk for serious ROP.

253 tion is exposure to radiations that put them at risk for severe cognitive dysfunction.

254 address the unmet needs of patients who are at risk for severe consequences of unchecked disease per

255 remains a prophylactic treatment for infants at risk for severe disease because of respiratory syncyt

256 iable predictive marker to identify patients at risk for severe disease exists.

257 chronic infections that place infected hosts at risk for severe disease.

258 screening modeled more hypothetical fetuses at risk for severe or profound conditions than did scree

259 cted on MRI scans at the time of an HSCT are at risk for severe, persistent neurocognitive deficits.

260 multiple sexual partners, which places them at risk for sexually transmitted infections.

261 ment sleep behavior disorder (IRBD) patients at risk for short-term development of clinically defined

262 atients with large ischemic cores who remain at risk for significant infarct expansion and thus could

263 em cell transplantation leaves the new liver at risk for similar EPP-related damage.

264 The odds of being at risk for social-emotional competence were 3.9 (95% CI

265 tics of stroke has not only identified those at risk for stroke but also identified ways to target at

266 ion in patients with atrial fibrillation and at risk for stroke, resulted in a significant increase i

267 mended for patients with atrial fibrillation at risk for stroke.

268 alone versus OAC prescription in AF patients at risk for stroke.

269 g lesions, it is important to identify those at risk for submucosal invasive cancer (SMIC).

270 r treated with cranial radiation therapy are at risk for subsequent CNS tumors.

271 g e-cigarettes, and these individuals may be at risk for subsequent progression to traditional cigare

272 hat this cohort may be aging prematurely and at risk for substantial medical and cognitive decline.

273 eliable prediction of which patient might be at risk for such events may help guide peri- and postope

274 Accurate identification of patients at risk for such events will allow patients to be better

275 ators (TV-ICDs) improve survival in patients at risk for sudden cardiac death, but complications rema

276 52-week predictions identified patients at risk for symptom persistence, non-adherence to treatm

277 linical use of antibiotics in young children at risk for T1D or CD.

278 peutic targets for immunotherapy in subjects at risk for T1D.

279 The latter group reflected dnDSA patients at risk for TG development (P < 0.001).

280 sed individuals who have symptoms of, or are at risk for, that disease.

281 This could suppress autoimmunity in those at risk for the development of T1D, as well as in those

282 ctive against allergy and asthma in children at risk for these outcomes.

283 impairment associated with schizophrenia are at risk for these practice effects, which can be difficu

284 ight hold the potential to identify patients at risk for this complication.

285 y injury (CI-AKI) for a subgroup of patients at risk for this complication.

286 recipients with exposures to animals may be at risk for this viral infection.

287 as led to a substantial increase in patients at risk for this vision-threatening disease.

288 undergoing transcatheter BHV replacement are at risk for thromboembolism in the first few months, and

289 These hotspots indicate areas at risk for transgressing regional constraints for fresh

290 ts are unaware of their infection, remaining at risk for transmission to others and disease progressi

291 igate 84 pathogens and the host species most at risk for transmission with wild pigs using a network

292 ng the correct identification of populations at risk for transmission within the United States.

293 receiving trastuzumab with chemotherapy are at risk for trastuzumab-related cardiac dysfunction (TRC

294 (HER2)-positive invasive breast cancer (IBC) at risk for treatment failure following trastuzumab and

295 rs of adolescent and young adult cancers are at risk for treatment-induced late adverse effects; howe

296 the development of autoimmunity in children at risk for type 1 diabetes (T1D).

297 rs before hyperglycemia develops in patients at risk for type 1 diabetes (T1D).

298 t by (1)H-MR spectroscopy in 449 individuals at risk for type 2 diabetes.

299 bilateral moderate or advanced glaucoma are at risk for unsafe driving-particularly those with impai

300 Survivors of EVD are at risk for uveitis, which may lead to secondary structu